Literature DB >> 17985010

Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.

Mohammad I Zia1, Shaun G Goodman, Eric D Peterson, Jyotsna Mulgund, Anita Y Chen, Anatoly Langer, Mary Tan, E Magnus Ohman, W Brian Gibler, Charles V Pollack, Matthew T Roe.   

Abstract

BACKGROUND: Practice guidelines support an early invasive strategy in patients with non-ST segment elevation acute coronary syndromes, particularly in those at higher risk.
OBJECTIVES: To compare North American rates of invasive cardiac procedure use stratified by risk.
METHODS: Use of invasive cardiac procedures and other care patterns in patients with non-ST segment elevation acute coronary syndromes from the United States (US) Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) National Quality Improvement Initiative (n=88,097; 465 hospitals) and Canadian ACS Registries I (n=1270; 51 hospitals) and II (n=1473; 36 hospitals) were compared after dividing patients into different risk categories based on predicted risk of in-hospital mortality.
RESULTS: While the overall use of invasive procedures was higher in the US, high-risk patients were least likely to undergo coronary angiography (41% versus 64% in Canada [P<0.0001] and 53% versus 76% in the United States [P<0.0001]) and percutaneous coronary intervention (14% versus 32% in Canada [P<0.0001] and 28% versus 51% in the US [P<0.0001]) compared with low-risk patients in both countries, and had longer median waiting times for these procedures (120 h versus 96 h in Canada [P<0.0001] and 34 h versus 23 h in the US [P<0.0001] for coronary angiography).
CONCLUSIONS: The inverse relationship between risk level and the use of invasive cardiac procedures for patients in the US and Canada suggests that a risk stratification-guided approach for triaging patients to an early invasive management strategy is paradoxically used. This incongruous relationship holds true regardless of resource availability or overall rates of cardiac catheterization.

Entities:  

Mesh:

Year:  2007        PMID: 17985010      PMCID: PMC2651932          DOI: 10.1016/s0828-282x(07)70876-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  33 in total

1.  Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.

Authors:  Andrew T Yan; Raymond T Yan; Mary Tan; Chi-Ming Chow; David Fitchett; Eric Stanton; Anatoly Langer; Shaun G Goodman
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

2.  Treating the right patient at the right time: access to care in non-ST segment elevation acute coronary syndromes.

Authors:  B J O'Neill; J M Brophy; C S Simpson; M M Sholdice; M Knutson; D B Ross; H Ross; J Rottger; Kevin Glasgow
Journal:  Can J Cardiol       Date:  2005-11       Impact factor: 5.223

3.  A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.

Authors:  W B Batchelor; E D Peterson; D B Mark; J D Knight; C B Granger; P W Armstrong; R M Califf
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

4.  Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome.

Authors:  Andrew T Yan; Philip Jong; Raymond T Yan; Mary Tan; David Fitchett; Chi-Ming Chow; Matthew T Roe; Karen S Pieper; Anatoly Langer; Shaun G Goodman
Journal:  Am Heart J       Date:  2004-12       Impact factor: 4.749

5.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

6.  Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

Authors:  Deepak L Bhatt; Matthew T Roe; Eric D Peterson; Yun Li; Anita Y Chen; Robert A Harrington; Adam B Greenbaum; Peter B Berger; Christopher P Cannon; David J Cohen; C Michael Gibson; Jorge F Saucedo; Neal S Kleiman; Judith S Hochman; William E Boden; Ralph G Brindis; W Frank Peacock; Sidney C Smith; Charles V Pollack; W Brian Gibler; E Magnus Ohman
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

7.  Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.

Authors:  S Yusuf; M Flather; J Pogue; D Hunt; J Varigos; L Piegas; A Avezum; J Anderson; M Keltai; A Budaj; K Fox; L Ceremuzynski
Journal:  Lancet       Date:  1998-08-15       Impact factor: 79.321

8.  Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes.

Authors:  Debabrata Mukherjee; Jianming Fang; Stanley Chetcuti; Mauro Moscucci; Eva Kline-Rogers; Kim A Eagle
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

9.  Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes.

Authors:  Ellen C Keeley; Rupin Kadakia; Sandeep Soman; Steven Borzak; Peter A McCullough
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

10.  Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

Authors:  Philippe Gabriel Steg; Omar H Dabbous; Laurent J Feldman; Alain Cohen-Solal; Marie-Claude Aumont; José López-Sendón; Andrzej Budaj; Robert J Goldberg; Werner Klein; Frederick A Anderson
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

View more
  8 in total

1.  Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

Authors:  Jasvinder A Singh; Jeff A Sloan; Pamela J Atherton; Tenbroeck Smith; Thomas F Hack; Mashele M Huschka; Teresa A Rummans; Matthew M Clark; Brent Diekmann; Lesley F Degner
Journal:  Am J Manag Care       Date:  2010-09       Impact factor: 2.229

2.  Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification.

Authors:  S Jedrzkiewicz; S G Goodman; R T Yan; R C Welsh; J Kornder; J Paul DeYoung; G C Wong; B Rose; F R Grondin; R Gallo; W Huang; J M Gore; A T Yan
Journal:  Can J Cardiol       Date:  2009-11       Impact factor: 5.223

3.  Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome.

Authors:  Shmuel Rispler; Doron Aronson; Sobhi Abadi; Ariel Roguin; Ahuva Engel; Rafael Beyar; Ora Israel; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-18       Impact factor: 9.236

4.  Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities Surveillance Study.

Authors:  Sameer Arora; Matthew A Cavender; Patricia P Chang; Arman Qamar; Wayne D Rosamond; Michael E Hall; Joseph S Rossi; Prashant Kaul; Melissa C Caughey
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2019-04-08

5.  Does a 'direct' transfer protocol reduce time to coronary angiography for patients with non-ST-elevation acute coronary syndromes? A prospective observational study.

Authors:  S M Gallagher; M J Lovell; D A Jones; E Ferguson; A Ahktar; Z Buckhoree; A Wragg; C J Knight; A Mathur; E J Smith; S Cliffe; R A Archbold; M T Rothman; A K Jain
Journal:  BMJ Open       Date:  2014-09-29       Impact factor: 2.692

6.  Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategies.

Authors:  Joakim Alfredsson; Kime Omar; József Csog; Dimitrios Venetsanos; Magnus Janzon; Mattias Ekstedt
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-12

7.  Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014.

Authors:  Sameer Arora; George A Stouffer; Anna Kucharska-Newton; Muthiah Vaduganathan; Arman Qamar; Kunihiro Matsushita; Dhaval Kolte; Harmony R Reynolds; Sripal Bangalore; Wayne D Rosamond; Deepak L Bhatt; Melissa C Caughey
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

8.  Current Status and Hospital-Level Differences in Care and Outcomes of Patients With Acute Non-ST-Segment Elevation Myocardial Infarction in China: Insights From China Acute Myocardial Infarction Registry.

Authors:  Qinghao Zhao; Haiyan Xu; Xuan Zhang; Yunqing Ye; Qiuting Dong; Rui Fu; Hui Sun; Xinxin Yan; Xiaojin Gao; Jingang Yang; Yang Wang; Yuejin Yang
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.